Login
$ICUI
$163.20 -$2.76 (1.66%) Close

$ICUI 3 SEC Filings

Filed On Filing
26 Feb 2024 Form 3: Sousa Ben, Chief Information Officer

Holds 123 shares of Common Stock

03 Feb 2022 Form 3: Seeger William, Director

No securities owned

24 Jan 2022 Form 3: Smiths Group Plc, 10% owner

Holds 2,500,000 shares of Common Stock

10 Jan 2022 Form 3: Smiths Group International Holdings Ltd, 10% owner

Holds 2,500,000 shares of Common Stock

04 Jan 2022 Form 3: Kennedy Kolleen T, Director

No securities owned

09 Jul 2021 Form 3: Hernandez Laurie, Director

Holds 100 shares of Common Stock

09 Mar 2020 Form 3: Bonnell Brian Michael, Chief Financial Officer
18 May 2018 Form 3: Woolson Daniel, VP, GM-Infusion Capital

Holds 1,763 shares of Common Stock

10 Jan 2018 Form 3: Voigtlander Christian B., Chief Operating Officer

Holds 34,426 shares of Common Stock

05 Jan 2018 Form 3: Abbey Donald, Director

No securities owned

05 Jan 2018 Form 3: Hoffmeister David F, Director

No securities owned

13 Feb 2017 Form 3: Pfizer Inc, Director and 3 others

Holds 3,200,000 shares of Common Stock

08 Feb 2017 Form 3: Giordano Douglas E., Director

No securities owned

16 Mar 2016 Form 3: Sanzone Virginia Ruth, VP, General Counsel
13 Jan 2016 Form 3: Finney Elisha W, Director

No securities owned

23 Jun 2015 Form 3: Greenberg David C., Director

Holds 500 shares of Common Stock

04 Aug 2014 Form 3: McGrody Kevin J, Controller

Holds 111 shares of Common Stock

31 Jul 2014 Form 3: McCall Thomas D, General Manager, Critical Care
21 Feb 2014 Form 3: Jain Vivek, Director

No securities owned

02 Oct 2006 Form 3: Lamb Scott E, Controller

Holds 510 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support